- 3.7Impact Factor
- 5.8CiteScore
- 17 daysTime to First Decision
Journal of Composites Science, Volume 6, Issue 9
September 2022 - 36 articles
Cover Story: Hemodialysis (HD) is a life-sustaining extracorporeal blood-purifying treatment for end-stage renal disease (ESRD) patients. However, this membrane-based therapy is associated with acute side effects, life-threatening chronic conditions, and unacceptably high morbidity and mortality rates. Heparin is a widely used anticoagulant substance that increases the clotting time and increases the membrane hemocompatibility. However, using heparin is challenging due to its severe or life-threatening side effects, such as heparin-induced thrombocytopenia (HIT), in addition to thrombosis (HITT). Therefore, the current study has thoroughly focused on different heparin HD membrane systems, the challenges of heparin-coated dialysis membranes, and the factors affecting its hemocompatibility, in addition to the methods that can be used to enhance its hemocompatibility. View this paper
- Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
- You may sign up for email alerts to receive table of contents of newly released issues.
- PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.
Articles
There are no articles in this issue yet.
Get Alerted
Add your email address to receive forthcoming issues of this journal.
J. Compos. Sci. - ISSN 2504-477X